Phase 1 study of concomitant tumor treating fields and temozolomide chemoradiation for newly diagnosed glioblastoma von Goldlust, Samuel A, Singer, Samuel, Cappello, Lori A, AlMekkawi, Ahmad K, Lee, Kangmin D, Ingenito, Anthony C, Lewis, Brett E, Nyirenda, Themba, Azmi, Hooman, Kaptain, George J

Volltext

ACTR-28. FINAL RESULTS FROM THE DOSE-ESCALATION STAGE OF A PHASE 1/2 TRIAL OF TPI 287, A BRAIN PENETRABLE MICROTUBULE INHIBITOR, PLUS BEVACIZUMAB IN PATIENTS WITH RECURRENT GLIOBLA... von Goldlust, Samuel, Nabors, Louis, Mohile, Nimesh, Benkers, Tara, Hsu, Sigmund, Silberman, Sandra, Singer, Samuel, Rao, Mayank, Cappello, Lori, Farmer, George

Volltext

Final results from the dose-escalation stage of a phase 1/2 trial of TPI 287, a brain penetrable microtubule inhibitor, plus bevacizumab in patients with recurrent glioblastoma von Goldlust, Samuel Aaron, Nabors, Louis B., Mohile, Nimish, Benkers, Tara L., Hsu, Sigmund H., Silberman, Sandra, Singer, Samuel, Rao, Mayank, Cappello, Lori, Farmer, George

Volltext

Phase 1 trial of TPI 287, a microtubule stabilizing agent, in combination with bevacizumab in adults with recurrent glioblastoma von Goldlust, Samuel A, Nabors, Louis B, Hsu, Sigmund, Mohile, Nimish, Duic, Paul J, Benkers, Tara, Singer, Samuel, Rao, Mayank, Cappello, Lori, Silberman, Sandra L, Farmer, George

Volltext